AGRICULTURAL TIMELINE 1867-2017

May 17, 2017

AGRICULTURE AND AGRI-FOOD CANADA CELEBRATES 150 YEARS OF AGRICULTURE. Naked Oats, a hulless, hairless oat variety is released, attracts new markets as a rice replacement, high-end animal feed and is also cheaper to transport.

Spotlight

POXEL

Poxel uses its development expertise in metabolism to advance a pipeline of drug candidates focused on the treatment of metabolic disorders, including type 2 diabetes. We have successfully completed our Phase 2 clinical program for our first-in-class lead product, Imeglimin, which targets mitochondrial dysfunction, in the U.S. and EU and Japan. Our second program, PXL770, a direct AMPK activator, is in Phase 1 development. We intend to generate further growth through strategic partnerships and pipeline development. Imeglimin is the first in a new chemical class of oral anti-diabetic agents, the Glimins. Imeglimin acts on three main target organs involved in glucose homeostasis: the liver, muscle, and the pancreas.

Other Infographics
news image

ACC Plastics Circular Economy

Infographic | December 4, 2019

100% of ACC’s Plastics Division’s U.S. manufacturing sites participate in Operation Clean Sweep-Blue by 2020, with all North American sites by 2022 Founding member of Global Declaration, which today includes 75 plastics organizations in 40 countries that have pledged to develop and track programs to help keep plastics out of our oceans

Read More
news image

Specialty Chemicals Market Overview

Infographic | December 26, 2019

The global specialty chemicals industry stood at almost $600 billion in 2018. Specialty polymers, industrial and institutional cleaners, electronic chemicals, surfactants, and flavors and fragrances were the largest sectors. Specialty chemicals are consumed in a wide variety of end use industries and growth is very much dependent on the health of the economy.

Read More
news image

MARKETING FOR SPECIALTY CHEMICAL COMPANIES

Infographic | December 26, 2019

Calibrating marketing endeavors so the right messages reach the right customers at the right time can be a significant challenge. Marketers in the specialty chemicals industry are keeping their eyes on the following issues to ensure they're providing value to their customers.

Read More
news image

PFAS WHAT YOU NEED TO KNOW

Infographic | December 28, 2019

WHAT ARE PFAS CHEMICALS? Per- and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals that includes PFOA, PFOS and GenX chemicals. Since the 1940s, PFAS have been manufactured and used in a variety of industries around the globe, including in the United States. PFOA and PFOS have been the most extensively produced and studied of these chemicals. Both are very persistent in the environment and in the human body. Exposure to certain PFAS can lead to adverse human health effects.

Read More
news image

PROCESS SAFETY AND HOW IT REDUCES YOUR RISK

Infographic | February 26, 2020

An effective process safety program combines management and engineering efforts to help mitigate accidents and catastrophes involving hazardous materials. PROCESS SAFETY (PS) IS NOT JUST A RESPONSE TO REGULATORY NEEDS; IT SAVES LIVES AND FINANCIAL COSTS TO A BUSINESS

Read More
news image

An overview on crude oil and refineries

Infographic | February 3, 2020

Crude oil undergoes a process called fractional distillation in the refinery plants. Crude oil is being heaten to crack down to shorter hydrocarbon chain under different temperature. The major by products are refinery gas, petrol, naphtha, kerosene, diesel, lubricating oil, fuel oil and bitumen.

Read More

Spotlight

POXEL

Poxel uses its development expertise in metabolism to advance a pipeline of drug candidates focused on the treatment of metabolic disorders, including type 2 diabetes. We have successfully completed our Phase 2 clinical program for our first-in-class lead product, Imeglimin, which targets mitochondrial dysfunction, in the U.S. and EU and Japan. Our second program, PXL770, a direct AMPK activator, is in Phase 1 development. We intend to generate further growth through strategic partnerships and pipeline development. Imeglimin is the first in a new chemical class of oral anti-diabetic agents, the Glimins. Imeglimin acts on three main target organs involved in glucose homeostasis: the liver, muscle, and the pancreas.

Events